Skip to main content
    AngelBacked

    eTheRNA immunotherapies

    BiotechnologyNiel, Antwerpen, BelgiumSeries B$111.9M total fundingwww.etherna.be

    Angel investors who backed eTheRNA immunotherapies

    22 investors in our database backed eTheRNA immunotherapies.

    Michelle Doig

    Board Observer

    Katie Kerfoot

    Vice President

    Paulina Hill

    Principal

    Otello Stampacchia

    Managing Director

    Anne Portwich

    Board Member

    Joachim Rothe

    Partner

    Rene Kuijten

    Partner, head of EQT Life Sciences (formerly LSP), member EQT Private Capital management team

    Merijn Klaassen

    CFO & COO

    Mark Wegter

    Partner

    Drew Burdon

    Board Member

    Rudy Dekeyser

    Member Board of Directors

    Martijn Kleijwegt

    Managing Partner

    Martin Heidecker

    Chief Investment Officer

    Alexander Ehlgen

    Executive Director / Investment Manager - Boehringer Ingelheim Venture Fund

    Johannes Zanzinger

    Investor @ BI Venture Fund

    Debbie Lin

    Investment Manager

    Sebastian Kreuz

    Executive Director / Investment Manager (BI Venture Fund)

    Detlev Mennerich

    Corporate SVP, Global Head of Business Development & Licensing (BD&L)

    Frank Kalkbrenner

    Director, Investment Manager

    Oliver Reuss

    Executive Director / Investment Manager; Boehringer Ingelheim Venture Fund

    Ilka Wicke Dr.

    Global Head Making More Health

    Chris Buyse

    Managing Partner

    View the full investor list for eTheRNA immunotherapies

    Find the right investors for your startup

    Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like eTheRNA immunotherapies.

    Search investors